Insights That Move the GPCR Field Forward

Discovery on Target returns to Boston September 28 to October 1, 2026, with GPCR science woven through the Lead Generation Strategies program. Ahead of the meeting, we spoke with four scientists presenting and teaching this year, from partial agonism to obesity targets to fragment screening against orphan receptors.

On April 29, GPCR scientists filled Pressed Cafe in Boston for the first Dr. GPCR Happy Hour of 2026. No slides, no panels, just the conversations that usually happen in hallways or never at all. Here is what the night looked like, and why it is exactly why this community exists.

Join us at the Discovery on Target meeting in Boston for the GPCR Drug Discovery track! I’m honored to chair a session featuring Terry Kenakin, a leader in functional selectivity. We’ll explore GPCR targets like GLP-1R, CXCR4, and dopamine receptors across oncology, metabolic, CNS, and immunology. As Dr. GPCR, we connect scientists and accelerate innovation — see you in Boston!